VEGFA and heart failure: In comparison, 141 patients would need to be treated with VEGF inhibitor therapy for one arterial thromboembolic event to occur, 139 patients for one case of cardiac dysfunction to be noted, and 410 patients for one clinical heart failure (CHF) presentation to evolve.